asset acquisition Labcorp to Acquire Myriad Genetics' Vectra Rheumatoid Arthritis Test for $150M The deal for the blood-based proteomic test, which measures disease activity in patients with rheumatoid arthritis, is expected to close in Q3 2021. Immunai Using Acquisition, Funding to Shift Into Functional Work Premium The immune profiling company is looking to expand its functional genomics capabilities to more directly inform immune therapy development and application. Immunai Acquires Dropprint Genomics The acquisition gives Immunai access to Dropprint's computational tools and to its database of immune cell profiles from autoimmune and cancer patients. Agilent Charges Into Liquid Biopsy Space with Resolution Bioscience Acquisition Premium The firm will build liquid biopsy companion diagnostic tests that complement its tissue-based assays and are tailored for drugs developed by pharma partners. 10x Genomics Acquires Denmark's Tetramer Shop The acquisition, 10x Genomics' fifth, could boost the firm's offerings for immune cell detection and discovery. Feb 17, 2021 Thermo Fisher Scientific Acquires Cell Sorting Technology From Propel Labs Oct 14, 2020 10x Genomics Acquisitions Point Towards New In Situ Analyisis Platform Premium Oct 14, 2020 Summa Equity Acquires Proteomics Firm Sengenics Oct 5, 2020 10x Genomics to Acquire ReadCoor for $350M, Cartana for $41.2M Sep 30, 2020 Bruker Acquires Software Platform From Integrated Proteomics Applications Jun 18, 2020 Illumina Acquires Informatics Firm BlueBee Mar 4, 2020 Abcam Acquires Marker Gene Technologies Feb 6, 2020 Quest Diagnostics Aims to Leverage Blueprint Acquisition to Advance Genetic Testing Portfolio Premium Jan 30, 2020 Abcam Acquires Applied StemCell Gene Editing Platform, Oncology Product Line Dec 18, 2019 Rapid Diagnostics Resurrects Multiplex MiniLab Platform, Targets TB POC Test Premium Nov 22, 2019 Phenomics Health Acquires Precera Pharmacometabolomic Technology Oct 25, 2019 Illumina Reserved in Comments on PacBio Deal, Forthcoming on Qiagen Deal and New Products Premium Oct 24, 2019 UK Regulators Propose Blocking $1.2B Illumina, PacBio Deal Aug 15, 2019 GeneCentric Therapeutics Acquires Select ImmunoGenomics Aug 6, 2019 Eurofins Genomics Buys Gene Synthesis Firm Blue Heron Jul 16, 2019 Abcam Acquires Knockout Cell Lines, Lysates Portfolio From EdiGene Jul 15, 2019 Interpace Dx Acquires Cancer Genetics' Biopharma Services Jul 15, 2019 Evotec Acquires iPSC Drug-Discovery Assets From Ncardia May 15, 2019 Ginkgo Bioworks Acquires Warp Drive Bio's Bioinformatics Platform Apr 30, 2019 Caprion Biosciences Buys Immune Monitoring Firm Serametrix Load More Breaking News UK Biobank Study Investigates Incomplete Penetrance of Mendelian Disease Variants MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.